Anna Jovanovich

691 total citations
28 papers, 502 citations indexed

About

Anna Jovanovich is a scholar working on Nephrology, Pathology and Forensic Medicine and Nutrition and Dietetics. According to data from OpenAlex, Anna Jovanovich has authored 28 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Nephrology, 8 papers in Pathology and Forensic Medicine and 8 papers in Nutrition and Dietetics. Recurrent topics in Anna Jovanovich's work include Parathyroid Disorders and Treatments (13 papers), Genetic and Kidney Cyst Diseases (6 papers) and Biomedical Research and Pathophysiology (5 papers). Anna Jovanovich is often cited by papers focused on Parathyroid Disorders and Treatments (13 papers), Genetic and Kidney Cyst Diseases (6 papers) and Biomedical Research and Pathophysiology (5 papers). Anna Jovanovich collaborates with scholars based in United States. Anna Jovanovich's co-authors include Michel Chonchol, Tamara Isakova, Jason R. Stubbs, Jessica Kendrick, Kristen L. Nowak, Gerard Smits, Zhiying You, Wei Wang, Berenice Y. Gitomer and Makoto Miyazaki and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

Anna Jovanovich

26 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Jovanovich United States 13 257 159 123 89 85 28 502
Silverio Rotondi Italy 12 277 1.1× 61 0.4× 82 0.7× 96 1.1× 76 0.9× 37 431
Bhupesh Panwar United States 12 189 0.7× 58 0.4× 39 0.3× 106 1.2× 70 0.8× 14 495
Jean‐Marc Hurot France 13 320 1.2× 126 0.8× 46 0.4× 32 0.4× 51 0.6× 30 590
Christine Houlihan Australia 13 235 0.9× 76 0.5× 40 0.3× 41 0.5× 110 1.3× 25 660
Edyta Gołembiewska Poland 11 189 0.7× 92 0.6× 30 0.2× 43 0.5× 36 0.4× 55 488
Timothy Ellam United Kingdom 14 320 1.2× 59 0.4× 29 0.2× 68 0.8× 83 1.0× 25 552
Steven Ing United States 12 77 0.3× 86 0.5× 37 0.3× 58 0.7× 95 1.1× 40 502
K. Sch�rer Germany 16 257 1.0× 150 0.9× 116 0.9× 63 0.7× 38 0.4× 40 671
Kirtikumar D Modi India 16 59 0.2× 82 0.5× 97 0.8× 96 1.1× 42 0.5× 49 645
Hung‐Chun Chen Taiwan 11 146 0.6× 114 0.7× 95 0.8× 24 0.3× 28 0.3× 15 416

Countries citing papers authored by Anna Jovanovich

Since Specialization
Citations

This map shows the geographic impact of Anna Jovanovich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Jovanovich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Jovanovich more than expected).

Fields of papers citing papers by Anna Jovanovich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Jovanovich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Jovanovich. The network helps show where Anna Jovanovich may publish in the future.

Co-authorship network of co-authors of Anna Jovanovich

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Jovanovich. A scholar is included among the top collaborators of Anna Jovanovich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Jovanovich. Anna Jovanovich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gitomer, Berenice Y., Wei Wang, Diana George, et al.. (2025). A randomized controlled trial evaluated the effect of pravastatin on kidney disease outcomes in adult patients with early-stage autosomal dominant polycystic kidney disease. Kidney International. 109(2). 390–397. 2 indexed citations
2.
Jovanovich, Anna, Wei Wang, Nina Z. Bispham, et al.. (2024). Effect of Lanthanum Carbonate on Serum Phosphate, Oxidative Stress, and Vascular Dysfunction in CKD. Kidney360. 5(7). 959–966.
3.
Nowak, Kristen L., Makoto Miyazaki, Michel Chonchol, et al.. (2021). Deoxycholic Acid (DCA) and Cognitive Impairment and Decline in the Chronic Renal Insufficiency Cohort (CRIC) Study. Journal of the American Society of Nephrology. 32(10S). 541–541.
4.
Cai, Xuan, Jungwha Lee, Joshua D. Bundy, et al.. (2021). Deoxycholic Acid and Risks of Cardiovascular Events, ESKD, and Mortality in CKD: The CRIC Study. Kidney Medicine. 4(1). 100387–100387. 17 indexed citations
5.
Nowak, Kristen L., Wei Wang, Zhiying You, et al.. (2021). Curcumin Therapy to Treat Vascular Dysfunction in Children and Young Adults with ADPKD. Clinical Journal of the American Society of Nephrology. 17(2). 240–250. 12 indexed citations
6.
Nowak, Kristen L., et al.. (2020). Vascular Dysfunction, Oxidative Stress, and Inflammation in Chronic Kidney Disease. Kidney360. 1(6). 501–509. 16 indexed citations
7.
Nowak, Kristen L., Melissa A. Cadnapaphornchai, Zhiying You, et al.. (2020). Curcumin therapy to treat vascular dysfunction in children and young adults with autosomal dominant polycystic kidney disease: Design and baseline characteristics of participants. Contemporary Clinical Trials Communications. 19. 100635–100635. 12 indexed citations
8.
Zhang, Shiqin, Cassandra Johnson, Raymond E. West, et al.. (2020). Randomized, Placebo-Controlled Trial of Rifaximin Therapy for Lowering Gut-Derived Cardiovascular Toxins and Inflammation in CKD. Kidney360. 1(11). 1206–1216. 14 indexed citations
9.
Nowak, Kristen L., Berenice Y. Gitomer, Wei Wang, et al.. (2019). Mineralocorticoid Antagonism and Vascular Function in Early Autosomal Dominant Polycystic Kidney Disease: A Randomized Controlled Trial. American Journal of Kidney Diseases. 74(2). 213–223. 21 indexed citations
10.
Jovanovich, Anna, et al.. (2019). Mineral Bone Abnormalities and Vascular Calcifications. Advances in Chronic Kidney Disease. 26(6). 409–416. 9 indexed citations
11.
Jovanovich, Anna, Zhiying You, Tamara Isakova, et al.. (2019). Fibroblast Growth Factor 23 Trajectories in Chronic Hemodialysis Patients: Lessons from the HEMO Study. American Journal of Nephrology. 49(4). 263–270. 12 indexed citations
12.
Nowak, Kristen L., Wei Wang, Berenice Y. Gitomer, et al.. (2018). Vascular Dysfunction, Oxidative Stress, and Inflammation in Autosomal Dominant Polycystic Kidney Disease. Clinical Journal of the American Society of Nephrology. 13(10). 1493–1501. 43 indexed citations
13.
Jovanovich, Anna & Jessica Kendrick. (2018). Personalized Management of Bone and Mineral Disorders and Precision Medicine in End-Stage Kidney Disease. Seminars in Nephrology. 38(4). 397–409. 19 indexed citations
14.
Jovanovich, Anna, Tamara Isakova, & Jason R. Stubbs. (2018). Microbiome and Cardiovascular Disease in CKD. Clinical Journal of the American Society of Nephrology. 13(10). 1598–1604. 53 indexed citations
15.
Jovanovich, Anna, Tamara Isakova, Geoffrey A. Block, et al.. (2017). Deoxycholic Acid, a Metabolite of Circulating Bile Acids, and Coronary Artery Vascular Calcification in CKD. American Journal of Kidney Diseases. 71(1). 27–34. 58 indexed citations
16.
Jovanovich, Anna & Michel Chonchol. (2015). Reductions in FGF-23 levels associated with improved outcomes. Nature Reviews Nephrology. 11(10). 572–573. 2 indexed citations
17.
Jovanovich, Anna, Michel B. Chonchol, Jessica Kendrick, et al.. (2015). Mineral Metabolites, Angiotensin II Inhibition and Outcomes in Advanced Chronic Kidney Disease. American Journal of Nephrology. 42(5). 361–368. 7 indexed citations
18.
Jovanovich, Anna, Michel Chonchol, Christopher B. Brady, et al.. (2014). 25-vitamin D, 1,25-vitamin D, parathyroid hormone, fibroblast growth factor-23 and cognitive function in men with advanced CKD: a veteran population. Clinical Nephrology. 82 (2014)(11). 296–303. 16 indexed citations
19.
Jovanovich, Anna, Joachim H. Ix, John S. Gottdiener, et al.. (2013). Fibroblast growth factor 23, left ventricular mass, and left ventricular hypertrophy in community-dwelling older adults. Atherosclerosis. 231(1). 114–119. 71 indexed citations
20.
Jovanovich, Anna, Michel Chonchol, Alfred K. Cheung, et al.. (2012). Racial Differences in Markers of Mineral Metabolism in Advanced Chronic Kidney Disease. Clinical Journal of the American Society of Nephrology. 7(4). 640–647. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silverio Rotondi Breakdown of academic impact, for papers by Bhupesh Panwar Breakdown of academic impact, for papers by Jean‐Marc Hurot Breakdown of academic impact, for papers by Christine Houlihan Breakdown of academic impact, for papers by Edyta Gołembiewska Breakdown of academic impact, for papers by Timothy Ellam Breakdown of academic impact, for papers by Steven Ing Breakdown of academic impact, for papers by K. Sch�rer Breakdown of academic impact, for papers by Kirtikumar D Modi Breakdown of academic impact, for papers by Hung‐Chun Chen
Rankless by CCL
2026